UBS raised the firm’s price target on Qualys to $170 from $162 and keeps a Neutral rating on the shares. Qualys’ Q4 results were mostly positive with current billings growth of 17% year over year, in line with expectations, and EBITDA margins of 46%, slightly ahead of expectations, the analyst tells investors in a research note. Without more concrete evidence of a reacceleration in 2H24, the firm thinks potential upside to shares will be challenging.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on QLYS:
- SHAREHOLDER ALERT: Potential Recovery for Qualys, Inc. (QLYS) Investors
- Qualys Announces Fourth Quarter and Full Year 2023 Financial Results
- Qualys updates Q4 reporting date to February 7
- Qualys under pressure as firm says Microsoft vulnerability partnership ending
- Qualys down 6% after Morgan Stanley says Microsoft partnership ending May 1
